NeurosciencebioRxivPreprint
A peripherally restricted cannabinoid 1 receptor agonist provides analgesic benefit from neuropathic pain and a lack of addiction-related behavior
Amie L. Severino, Lindsay M. Lueptow, Emily Ellis…·Catherine M. Cahill
This study evaluates a peripherally restricted CB1 agonist for neuropathic pain relief and addiction risk, finding it reduces pain without promoting drug-seeking behavior.
DOI 10.64898/2026.04.13.718281